TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells
Open Access
- 6 September 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 12 (1), 391
- https://doi.org/10.1186/1471-2407-12-391
Abstract
Background Hypoxia is a common characteristic of solid tumors associated with reduced response to radio- and chemotherapy, therefore increasing the probability of tumor recurrence. The aim of this study was to identify new mechanisms responsible for hypoxia-induced resistance in breast cancer cells. Methods MDA-MB-231 and HepG2 cells were incubated in the presence of taxol or etoposide respectively under normoxia and hypoxia and apoptosis was analysed. A whole transcriptome analysis was performed in order to identify genes whose expression profile was correlated with apoptosis. The effect of gene invalidation using siRNA was studied on drug-induced apoptosis. Results MDA-MB-231 cells incubated in the presence of taxol were protected from apoptosis and cell death by hypoxia. We demonstrated that TMEM45A expression was associated with taxol resistance. TMEM45A expression was increased both in MDA-MB-231 human breast cancer cells and in HepG2 human hepatoma cells in conditions where protection of cells against apoptosis induced by chemotherapeutic agents was observed, i.e. under hypoxia in the presence of taxol or etoposide. Moreover, this resistance was suppressed by siRNA-mediated silencing of TMEM45A. Kaplan Meier curve showed an association between high TMEM45A expression and poor prognostic in breast cancer patients. Finally, TMEM45 is highly expressed in normal differentiated keratinocytes both in vitro and in vivo, suggesting that this protein is involved in epithelial functions. Conclusion Altogether, our results unravel a new mechanism for taxol and etoposide resistance mediated by TMEM45A. High levels of TMEM45A expression in tumors may be indicative of potential resistance to cancer therapy, making TMEM45A an interesting biomarker for resistance.Keywords
This publication has 62 references indexed in Scilit:
- RAB8 Enhances TMEM205-Mediated Cisplatin ResistancePharmaceutical Research, 2011
- Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistanceJournal of Cellular Physiology, 2010
- Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxiaMolecular Cancer, 2010
- Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cellsBMC Cancer, 2010
- Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer ManagementObstetrics and Gynecology International, 2010
- An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxiaNucleic Acids Research, 2009
- Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1Molecular Cancer Therapeutics, 2009
- Neurophysiological evaluation of healthy human anorectal sensationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Hypoxia induces the expression of the pro-apoptotic gene BNIP3Cell Death & Differentiation, 2001